Diagnostic Ultrasound Market size to exceed $11 Bn by 2032

Diagnostic Ultrasound Market size is projected to be valued at over USD 11 billion by 2032, according to a new research report by Global Market Insights Inc.
 

The rising elderly population susceptible to chronic diseases is a prominent reason behind the mounting adoption of diagnostic ultrasound imaging tests, the report claims. As per the WHO, by 2030, 1 in 6 people will be aged 65 years and above. The incidence of age-related chronic conditions will therefore rise and consequently augment the need for diagnostic medical ultrasound procedures to treat health conditions. The awareness of the availability of effective imaging techniques for disease management has also surged, further accelerating the sales of diagnostic ultrasound equipment.
 

Increasing usage of dopplers will boost popularity of 3D & 4D diagnostic ultrasound devices

The diagnostic ultrasound market share from the 3D and 4D segment is slated to depict over 4% CAGR by 2032. This growth is considering the ability to detect abnormalities more than 2D imaging, mainly due to reduced waiting time for 4D scanning. These scanners can also ensure multifactorial benefits such as efficient skeletal diagnosis, fetal heart structure visualization, and neural tube defect detection. The growing consumption of dopplers to determine blood pressure and flow will drive the acceptance of 3D and 4D ultrasound tests.
 

Preference for lightweight equipment over CT scanners spur compact/handheld ultrasound device use

Diagnostic ultrasound market size from the compact/handheld portability segment reached USD 2 billion in 2022, given the strong demand for lightweight and smart diagnostic systems. Handheld ultrasound devices have become a preferred choice over X-rays and CT scans, owing to their small size, mobility, and other key benefits. Moreover, the increased preference for compact medical devices in emergency rooms, ICUs, and operating rooms will bolster the production of handheld diagnostic ultrasound equipment.
 

Browse key industry insights spread across 220 pages with 352 market data tables & 19 figures & charts from the report, “Diagnostic Ultrasound Market Size By Technology (2D, 3D and 4D, Doppler), By Portability (Trolley, Compact/Handheld), By Application (General Imaging, Cardiology, Obstetrics/Gynecology), By End-use (Hospitals, Maternity Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” In detail along with the table of contents:
https://www.gminsights.com/industry-analysis/diagnostic-ultrasound-market
 

Rising prevalence of gallstone disease fuels diagnostic ultrasound test popularity for general imaging

General imaging segment accounted for over 40% share of the diagnostic ultrasound market in 2022. The need for diagnostic systems for the examination of the abdomen, kidneys, gallbladder, liver spleen, pancreas, and other body parts will propel ultrasound equipment production. Gallbladder cancer has become a major disease burden, especially in America, leading to the high acceptance of radiologically diagnostic procedures. Factors such as these will augment the development of diagnostic ultrasound devices for general imaging applications.
 

Emphasis on early disease detection boosts the rate of ultrasound procedures in hospitals

Hospitals segment held more than 50% share of the diagnostic ultrasound market in 2022, which can be credited to the increasing use of ultrasound systems for early disease diagnosis. These devices can also help determine disease progressions, further contributing to their usage in hospital settings. The report cites that the presence of skilled healthcare professionals and advanced equipment installation will drive the adoption of diagnostic ultrasound procedures in hospital settings.
 

Increase in breast cancer incidence to expedite diagnostic ultrasound device development in Europe

Europe diagnostic ultrasound market size is projected to be over USD 2.5 billion by 2032, due to the high burden of chronic diseases. This growing incidence of chronic ailments such as breast cancer will amplify the usage of diagnostic breast ultrasound devices across Europe.
 

Product launch initiatives by major participants will impact industry landscape

Samsung Electronics Co. Ltd., Koninklijke Philips N.V. (BioTelemetry, Inc.), Hologic, Inc., General Electric Company (GE Healthcare), Fujifilm Holdings Corporation, Canon Medical Systems Corporation, and Siemens Healthineers AG are among the prominent players.